Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas

Li, Y., Goldberg, E. M., Chen, X., Xu, X., McGuire, J. T., Leuzzi, G., Karagiannis, D., Tate, T., Farhangdoost, N., Horth, C., Dai, E., Li, Z., Zhang, Z., Izar, B., Que, J., Ciccia, A., Majewski, J., Yoon, A. J., Ailles, L., … Lu, C. (2022). Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas. Molecular Cell, 82(20), 3901-3918.e7. https://doi.org/10.1016/j.molcel.2022.09.007
Authors:
Yinglu Li
Elizabeth M. Goldberg
Xiao Chen
Xinjing Xu
John T. McGuire
Giuseppe Leuzzi
Dimitris Karagiannis
Tiffany Tate
Nargess Farhangdoost
Cynthia Horth
Esther Dai
Zhiming Li
Zhiguo Zhang
Benjamin Izar
Jianwen Que
Alberto Ciccia
Jacek Majewski
Angela J. Yoon
Laurie Ailles
Cathy Mendelsohn
Chao Lü
Affiliated Authors:
Yinglu Li
Elizabeth M. Goldberg
Xiao Chen
Xinjing Xu
John T. McGuire
Giuseppe Leuzzi
Dimitris Karagiannis
Tiffany Tate
Esther Dai
Zhiming Li
Zhiguo Zhang
Benjamin Izar
Jianwen Que
Alberto Ciccia
Angela J. Yoon
Cathy Mendelsohn
Chao Lü
Author Keywords:
dna methylation
ezh2
nsd1
tazemetostat
epigenetics
head and neck cancers
histone methylation
immune evasion
squamous cell carcinomas
Publication Type:
Article
Unique ID:
10.1016/j.molcel.2022.09.007
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: